TEVA · Teva Pharmaceutical Industries Ltd

$30.81 -0.37 (-1.19%) At close · Jul 24

Market Cap

$35.88B

1.16B

Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score

67/100

Short interest 2.8% of shares — P57 Days to cover 6.5 — P77 Price vs VWAP -8.7% — P31 Short-volume trend +11.6% — P80 Short interest change +2.2% — P58 Worst FTD 0.00% of shares — P17 Earnings soon +10

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All

Short Interest History

Settlement Date	Current Position	Previous Position	Change	Avg Daily Volume	Days to Cover
2026-08-14 Scheduled FINRA publishes Aug 25	—	—	—	—	—
2026-07-31 Scheduled FINRA publishes Aug 11	—	—	—	—	—
2026-07-15	32,741,011	32,029,657	+711,354	5,031,824	6.51
2026-06-30	32,029,657	33,346,891	-1,317,234	6,283,326	5.10
2026-06-15	33,346,891	33,869,008	-522,117	6,149,216	5.42
2026-05-29	33,869,008	26,651,458	+7,217,550	5,646,510	6.00
2026-05-15	26,651,458	31,140,457	-4,488,999	6,682,365	3.99
2026-04-30	31,140,457	29,736,398	+1,404,059	7,780,794	4.00
2026-04-15	29,736,398	27,042,748	+2,693,650	4,191,168	7.10
2026-03-31	27,042,748	37,623,025	-10,580,277	7,063,669	3.83
2026-03-13	37,623,025	32,527,649	+5,095,376	8,864,221	4.24
2026-02-27	32,527,649	36,644,722	-4,117,073	6,457,336	5.04
2026-02-13	36,644,722	37,953,087	-1,308,365	10,104,694	3.63
2026-01-30	37,953,087	32,969,413	+4,983,674	10,894,419	3.48
2026-01-15	32,969,413	32,862,069	+107,344	11,356,232	2.90
2025-12-31	32,862,069	44,936,239	-12,074,170	6,967,049	4.72
2025-12-15	44,936,239	45,620,941	-684,702	10,908,959	4.12
2025-11-28	45,620,941	46,443,487	-822,546	10,577,486	4.31
2025-11-14	46,443,487	50,392,932	-3,949,445	18,429,877	2.52
2025-10-31	50,392,932	47,284,149	+3,108,783	8,663,070	5.82
2025-10-15	47,284,149	49,879,298	-2,595,149	8,949,285	5.28
2025-09-30	49,879,298	55,193,262	-5,313,964	11,232,796	4.44
2025-09-15	55,193,262	50,507,199	+4,686,063	10,307,481	5.35
2025-08-29	50,507,199	46,260,428	+4,246,771	10,749,875	4.70
2025-08-15	46,260,428	49,888,340	-3,627,912	11,244,161	4.11
2025-07-31	49,888,340	53,422,754	-3,534,414	13,514,249	3.69

Showing 1–24 of 24 settlements

Key facts CIK 818686 CUSIP 881624209 13F (30d) 156 filings 144 filers Visit website Investor relations